US BANCORP \DE\ - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 268 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$666,017
-12.1%
41,967
+4.6%
0.00%0.0%
Q2 2023$757,423
+86760.4%
40,139
+17582.4%
0.00%
Q1 2023$872
-22.6%
2270.0%0.00%
Q4 2022$1,126227
+567.6%
0.00%
Q4 2021$0
-100.0%
34
-93.3%
0.00%
Q3 2021$3,0000.0%507
+7.2%
0.00%
Q2 2021$3,000
-40.0%
473
-30.0%
0.00%
Q1 2021$5,000
+66.7%
676
+42.9%
0.00%
Q4 2020$3,0000.0%473
-19.7%
0.00%
Q4 2019$3,000
+200.0%
589
+4.6%
0.00%
Q3 2019$1,000563
+329.8%
0.00%
Q2 2019$0
-100.0%
131
-99.1%
0.00%
Q1 2019$42,000
-43.2%
15,246
-0.8%
0.00%
Q4 2018$74,000
-50.7%
15,376
-3.0%
0.00%
Q3 2018$150,000
-3.2%
15,846
-0.3%
0.00%
Q2 2018$155,000
-7.2%
15,8880.0%0.00%
-100.0%
Q1 2018$167,000
+74.0%
15,888
+5.9%
0.00%
Q4 2017$96,000
-16.5%
15,0000.0%0.00%
Q3 2017$115,000
+7.5%
15,0000.0%0.00%
Q2 2017$107,000
+81.4%
15,000
-2.0%
0.00%
Q1 2017$59,000
+195.0%
15,300
+136.8%
0.00%
Q2 2016$20,000
-25.9%
6,460
+99.1%
0.00%
Q1 2016$27,000
+1250.0%
3,244
+2474.6%
0.00%
Q4 2015$2,000
-60.0%
126
-77.1%
0.00%
Q3 2015$5,000
+400.0%
550
+175.0%
0.00%
Q4 2014$1,000
-50.0%
200
-17.0%
0.00%
Q3 2014$2,0000.0%241
+20.5%
0.00%
Q2 2014$2,000
-33.3%
2000.0%0.00%
Q1 2014$3,0000.0%2000.0%0.00%
Q4 2013$3,000
-40.0%
200
-40.3%
0.00%
Q3 2013$5,000
-86.5%
335
-85.0%
0.00%
Q2 2013$37,0002,2270.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders